EUVIMEDEUVIMED entdecken
Crossref

The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience

Gabriella Maioli, Gilberto Cincinelli, Martina Biggioggero, Roberto Caporali, Ennio Giulio Favalli

Clinical and Experimental Rheumatology · 2023

DOI: 10.55563/clinexprheumatol/c4pgcd ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Rheumatology, 2023. Verfasst von Gabriella Maioli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milan, and Department of Clinical Sciences and Community Health, Un…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Biological Products, Registries.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To evaluate the change over time in the pattern of the first biologic/targeted synthetic drug (b/tsDMARD) prescription and baseline characteristics in patients with rheumatoid arthritis (RA) from 1999 to the present. METHODS: A retrospective data analysis from RA patients enrolled in an Italian single-center registry was conducted. The analysis was limited to all the patients who received the first b/tsDMARD between October 1999 and December 2022. Patients were stratified according to the date of b/tsDMARD initiation into 4 groups (1999-2004, 2005-2010, 2011-2016, and 2017-2022) and a comparative analysis of prescription patterns and patients' baseline characteristics was performed. RESULTS: The study population included 1206 patients. The characteristics of patients at baseline in the 4 groups were similar overall, with the exception of disease duration (12.26, 10.5, 9.7, 8.1 years, respectively; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsBiological ProductsRegistriesPractice Patterns, Physicians'HumansMaleFemaleMiddle AgedRetrospective StudiesAgedTime FactorsItalyTreatment FailureAdultDrug PrescriptionsMolecular Targeted Therapy

Substanzen

Antirheumatic AgentsBiological Products

Autor:innen und Institutionen

  • Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milan, and Department of Clinical Sciences and Community Health, University of Milan, Italy.
  • Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milan, Italy.
  • Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milan, and Department of Clinical Sciences and Community Health, University of Milan, Italy. ennio.favalli@unimi.it.

Zitieren

APA

Maioli, G., Cincinelli, G., Biggioggero, M., Caporali, R., & Favalli, E. G. (2023). The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/c4pgcd

Vancouver

Maioli G, Cincinelli G, Biggioggero M, Caporali R, Favalli EG. The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience. Clinical and Experimental Rheumatology. 2023. doi:10.55563/clinexprheumatol/c4pgcd

BibTeX
@article{Maioli2023,
  author = {Maioli, Gabriella and Cincinelli, Gilberto and Biggioggero, Martina and Caporali, Roberto and Favalli, Ennio Giulio},
  title = {The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience},
  journal = {Clinical and Experimental Rheumatology},
  year = {2023},
  doi = {10.55563/clinexprheumatol/c4pgcd}
}
Kostenlos starten →